Okechukwu Okoye
Internal Medicine · Hagerstown, MDNPI 1174083711
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,888 of the $4,278 with a category attached, or 67.5%. 15 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 38.2% of the total. 2025 is the largest year on record at $3,744, more than ten times the $116 reported in 2021. Among internal medicine clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 107 payments — averaging $39.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Amgen$580
- Johnson & Johnson$497
- AbbVie$463
- AstraZeneca$430
- GSK$230
- plus $443 from 9 others
Across 2 payments — averaging $8324.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$17K
What the payments were for
- Travel & lodging$1,31131%
- Food & beverage$2,88868%
- Education$792%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $1,636 |
| Amgen | 24 | $580 |
| Johnson & Johnson(2 entities) | 8 | $497 |
| AbbVie | 22 | $463 |
| AstraZeneca | 18 | $430 |
| GSK | 5 | $230 |
| Radius Health, Inc. | 4 | $102 |
| Boston Scientific | 2 | $79 |
| Mallinckrodt Hospital Products Inc. | 2 | $60 |
| UCB, Inc. | 2 | $53 |
| ANI Pharmaceuticals, Inc. | 2 | $42 |
| Fresenius Kabi USA, LLC | 2 | $36 |
| Novartis | 1 | $31 |
| Sanofi | 1 | $25 |
| Sandoz | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,278 in reported general payments places this provider in the 90th percentile of 2,979 internal medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Actemra ActpenTocilizumab | 18 | $83,049 |
| Mycophenolate Mofetil | 21 | $1,497 |
| Leflunomide | 37 | $1,467 |
| Hydroxychloroquine Sulfate | 45 | $1,162 |
| MethotrexateMethotrexate Sodium | 59 | $959 |
| Colchicine | 11 | $502 |
| Prednisone | 67 | $295 |
| Allopurinol | 21 | $291 |
| Diclofenac Sodium | 13 | $171 |
| Methotrexate SodiumMethotrexate Sodium/Pf | 11 | $131 |
| Alendronate Sodium | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Hagerstown
- Marianne MannHighland$2.1M
- Param DedhiaBaltimore$636K
- Curtis RosebraughAshton$418K
- Mark CorriereColumbia$402K
- Gregory PokrywkaTowson$377K
- Shawn DhillonBaltimore$227K
- Brian HarveyAnnapolis$220K
- Jeremy SugarmanBaltimore$210K
- Florence HounPotomac$161K
- Matthew MintzBethesda$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.